HomeDealsSynthomer

Synthomer

Deal Type
Deal Type
Company sale
Vital Sector
Sector
Industrials
Completion Date
Completion Date
31st May 2025
Deal Value
Deal Value
£30m

Company Background

William Blythe has pioneered the development and use of inorganic derivatives of elements such as tin, iodine, copper, zinc and tungsten for demanding applications in markets including life sciences, performance coatings, polymers, electronics, catalysts and renewable energy for 180 years.

Deal Summary

Opus advised Synthomer Plc on its divestment of William Blythe Ltd to its management team and H2 Equity Partners, for £30m.

Synthomer deal contacts

Key members of the Opus Corporate Finance deal team crucial in the Synthomer transaction

Chris Carlisle

Opus Corporate Finance

Arun Malhi

Opus Corporate Finance

Ed Batchelor

Opus Corporate Finance

Daniel Barley

Opus Corporate Finance